Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-10

Clinical Trial Update: Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

View source ↗

Summary

A clinical trial update from MD Anderson evaluating nanosecond pulsed field ablation for benign thyroid nodules. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Thyroid Nodules, Pulsed Field Ablation | Status: NOT_YET_RECRUITING